| Mar 1, 2026 |
Mar 3, 2026 |
Etkin Amit
|
CEO |
Sell |
32.5
|
-6,227
|
-0.50%
|
✗
|
$122.6K |
| Mar 1, 2026 |
Mar 3, 2026 |
Smith Nicholas Conrad
|
CFO |
Sell |
22.5
|
-2,806
|
-10.44%
|
✗
|
$55.3K |
| Feb 11, 2026 |
Feb 13, 2026 |
Etkin Amit
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 11, 2026 |
Feb 13, 2026 |
Savitz Adam
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 11, 2026 |
Feb 13, 2026 |
Smith Nicholas Conrad
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 11, 2026 |
Feb 13, 2026 |
Hanley Jr. Michael Conick
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
York Gwill
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Cox Christopher Nixon
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Manji Husseini
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Sanchez Ramiro
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 12, 2025 |
Aug 14, 2025 |
Sanchez Ramiro
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 14, 2025 |
Sanchez Ramiro
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2025 |
Jul 8, 2025 |
Hanley Jr. Michael Conick
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2025 |
Jul 8, 2025 |
Savitz Adam
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2025 |
Jul 8, 2025 |
Etkin Amit
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2025 |
Jul 8, 2025 |
Smith Nicholas Conrad
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
Manji Husseini
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
Cox Christopher Nixon
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
Dreyfus Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
York Gwill
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 5, 2025 |
Feb 7, 2025 |
Hanley Jr. Michael Conick
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 5, 2025 |
Feb 7, 2025 |
Smith Nicholas Conrad
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 5, 2025 |
Feb 7, 2025 |
Savitz Adam
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 5, 2025 |
Feb 7, 2025 |
Etkin Amit
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
York Gwill
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
Manji Husseini
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
Cox Christopher Nixon
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 9, 2024 |
Jul 11, 2024 |
Savitz Adam
|
CHIEF MEDICAL OFFICER |
Buy |
95.0
|
+15,000
|
60.36%
|
✗
|
$190.8K |
| May 20, 2024 |
May 22, 2024 |
Hanley Jr. Michael Conick
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 22, 2024 |
Hanley Jr. Michael Conick
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 28, 2024 |
Apr 1, 2024 |
Smith Nicholas Conrad
|
CFO |
Buy |
95.0
|
+6,150
|
29.69%
|
✗
|
$100.6K |
| Mar 8, 2024 |
Mar 12, 2024 |
Radhakrishnan Maha
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 12, 2024 |
Radhakrishnan Maha
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 6, 2024 |
Mar 6, 2024 |
Apeiron Investment Group Ltd.
|
Other |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2024 |
Mar 5, 2024 |
Savitz Adam
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2024 |
Mar 5, 2024 |
Etkin Amit
|
CEO |
Neutral |
82.5
|
+34,711
|
2.88%
|
✗
|
- |
| Mar 1, 2024 |
Mar 5, 2024 |
Smith Nicholas Conrad
|
CFO |
Neutral |
90.0
|
+19,153
|
1225.40%
|
✗
|
- |
| Feb 6, 2024 |
Feb 8, 2024 |
Alpha Wave Global, LP
|
10% Owner |
Buy |
100.0
|
+600,000
|
19.31%
|
✗
|
$9.6M |
| Feb 6, 2024 |
Feb 7, 2024 |
York Gwill
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 6, 2024 |
Feb 7, 2024 |
Smith Nicholas Conrad
|
CFO |
Buy |
91.3
|
+1,563
|
100.00%
|
✗
|
$25K |
| Feb 6, 2024 |
Feb 7, 2024 |
Cox Christopher Nixon
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 6, 2024 |
Feb 7, 2024 |
Savitz Adam
|
CHIEF MEDICAL OFFICER |
Buy |
97.5
|
+17,000
|
216.53%
|
✗
|
$272K |
| Feb 6, 2024 |
Feb 7, 2024 |
Etkin Amit
|
CEO |
Buy |
65.0
|
+3,125
|
0.26%
|
✗
|
$50K |
| Feb 6, 2024 |
Feb 7, 2024 |
Chen Po Yu (Jeff)
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
York Gwill
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
Manji Husseini
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
Chen Po Yu (Jeff)
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
Cox Christopher Nixon
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
Dreyfus Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 2, 2024 |
Apeiron Investment Group Ltd.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2024 |
Manji Husseini
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2024 |
Dreyfus Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2024 |
Alpha Wave Ventures GP, Ltd
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2024 |
Etkin Amit
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2024 |
York Gwill
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2024 |
Smith Nicholas Conrad
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2024 |
ALKEON CAPITAL MANAGEMENT LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2024 |
Cox Christopher Nixon
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2024 |
Savitz Adam
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2024 |
Chen Po Yu (Jeff)
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |